Matthew Robinson
Equibles does not estimate personal net worth.
Get an email with a short summary when Immunome Inc. publishes a filing, an earnings call transcript or a press release.
Get IMNM alertsAbout Matthew Robinson
Immunome Inc. reported in an 8-K filed October 4, 2023 that Matthew Robinson was appointed Chief Discovery Officer, Biology, effective October 2, 2023. Immunome Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Immunome Inc. includes Clay B. Siegall, Ph.D. (CEO), Clay Siegall (CEO), Corleen Roche (CFO) and 7 others.
“Immediately following the effective time of the Merger, Immunome's board of directors (and its committees) and executive officers were reconstituted to include the following directors and executive officers”
Affiliation history
-
Immunome Inc. (IMNM)
SEC 8-K
Current2023-10-02–present
Company network
Leadership on record at Immunome Inc.
- Clay B. Siegall, Ph.D. CEO
- Clay Siegall CEO
- Corleen Roche CFO
- Diane Marcou CFO
- Max Rosett CFO
- Matthew K. Robinson CTO
- Sandra Stoneman General Counsel
- Bob Lapetina Chief Accounting Officer
- Carol Schafer Board Member
- Franklyn G. Prendergast, M.D., Ph.D. Board Member